<div><p>Background</p><p>Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical course of sickle cell disease (SCD). Data on this important aspect of SCD have not yet been reported from West Africa. We investigated the relationship between HbF levels and the relevant genetic loci in 610 patients with SCD (98% HbSS homozygotes) from Cameroon, and compared the results to a well-characterized African-American cohort.</p><p>Methods and Findings</p><p>Socio-demographic and clinical features were collected and medical records reviewed. Only patients >5 years old, who had not received a blood transfusion or treatment with hydroxyurea were included. Hemoglobin electrophoresis and a full blood count were con...
International audienceAims: Fetal hemoglobin (HbF) modulates the phenotype of sickle cell anemia (SC...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...
Background: Genetic variation at loci influencing adult levels of HbF have been shown to modify the ...
Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical cou...
Variants in BCL11A were previously associated with fetal hemoglobin (HbF) levels among Cameroonian s...
Fetal hemoglobin (HbF, α(2)γ(2)) is a major contributor to the remarkable phenotypic heterogeneity o...
Background: Reactivation of adult hemoglobin (HbF) is currently a dominant therapeutic approach to s...
<div><p>Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), <i>BCL1...
Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), BCL11A, HBS1L-M...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
Patients with sickle cell disease (SCD) in Kuwait have elevated HbF levels ranging from ~10–44%; how...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
peer reviewedBACKGROUND: We aimed to investigate the distribution of selected BCL11A and HMIP polymo...
International audienceAims: Fetal hemoglobin (HbF) modulates the phenotype of sickle cell anemia (SC...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...
Background: Genetic variation at loci influencing adult levels of HbF have been shown to modify the ...
Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical cou...
Variants in BCL11A were previously associated with fetal hemoglobin (HbF) levels among Cameroonian s...
Fetal hemoglobin (HbF, α(2)γ(2)) is a major contributor to the remarkable phenotypic heterogeneity o...
Background: Reactivation of adult hemoglobin (HbF) is currently a dominant therapeutic approach to s...
<div><p>Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), <i>BCL1...
Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), BCL11A, HBS1L-M...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
Patients with sickle cell disease (SCD) in Kuwait have elevated HbF levels ranging from ~10–44%; how...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a ...
peer reviewedBACKGROUND: We aimed to investigate the distribution of selected BCL11A and HMIP polymo...
International audienceAims: Fetal hemoglobin (HbF) modulates the phenotype of sickle cell anemia (SC...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...
Fetal hemoglobin (HbF) is an important modulator of sickle cell disease (SCD). HbF has previously be...